RaySearch receives Chinese regulatory approval For RayStation

RaySearch Laboratories AB has received regulatory market approval by the Chinese regulatory agency CFDA for RaySearch’s treatment planning system RayStation. The approval means that RayStation can now be sold on the Chinese market.

Since November 2011, RaySearch is represented on the Chinese market by the distributor Kang Li Da Trading Corporation, based in Beijing. Kang Li Da has so far been active in pre-marketing activities and in the regulatory process to get CFDA approval. Now when market approval has been secured Kang Li Da will be fully responsible for marketing, sales and service for RayStation on the entire Chinese market.

China is one of the largest radiation therapy markets globally with approximately 1300 radiation therapy clinics. There is a strong focus on improving healthcare so the radiation therapy sector is growing very rapidly and the number of clinics is expected to increase to 2,000 in less than five years.

For more information: www.raysearchlabs.com